Zosano Pharma Corp
ZSANDelisted Jul 19, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001587221
Zosano Pharma Corp was delisted on Jul 19, 2022; its insiders filed their last Form 4 on Jun 7, 2022; 30 institutions reported holding it in 13F filings for Q1 2022, worth $2.89M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Zosano Pharma Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Zosano Pharma Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lo Steven | Chief Executive Officer | 13,163 | Jun 7, 2022 | 0 |
| Matthews Christine | Chief Financial Officer | 4,183 | Jun 7, 2022 | 0 |
| Kellerman Donald J | VP, Clinical Dev & Med Affairs | 56,331 | Apr 1, 2022 | 0 |
| Yang Elaine | Director | – | Dec 9, 2021 | 0 |
| Greathouse Kenneth | Director | 43,500 | Nov 24, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Matthews ChristineChief Financial Officer | SSale | −82 | $0.71 | −$58.22 | −1.9%4.18K after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Lo StevenChief Executive Officer | SSale | −442 | $0.71 | −$313.82 | −3.2%13.2K after | |
| Apr 1, 2022 (view filing)9:09 PM ET | Mar 31 | 1 day | Matthews ChristineChief Financial Officer | SSale | −8.12K | $0.2101 | −$1.71K | −5.3%146.4K after | |
| Apr 1, 2022 (view filing)9:08 PM ET | Mar 31 | 1 day | Kellerman Donald JVP, Clinical Dev & Med Affairs | SSale | −4.01K | $0.2101 | −$841.66 | −6.6%56.3K after | |
| Apr 1, 2022 (view filing)9:07 PM ET | Mar 31 | 1 day | Lo StevenChief Executive Officer | SSale | −23.6K | $0.2101 | −$4.97K | −4.9%460.7K after | |
| Nov 24, 2021 (view filing) | Nov 23 | 1 day | Greathouse KennethDirector | SSale | −10.0K | $0.60 | −$6.00K | −18.7%43.5K after |